Health Monitor Liechtenstein

AGP Executive Report

Last update: 10 hours ago

Rare-Disease Treatment: The European Commission has authorized Nezglyal under exceptional circumstances for boys aged 2–12 with cerebral adrenoleukodystrophy and brain lesions. It is the first EU-approved medicine for early intervention in the aggressive disease. Biopharma Deals: September’s deals included Telix Pharmaceuticals’ planned merger with radiopharmaceuticals company ITM, valued at up to $2.35 billion, and GSK’s purchase of a multiple-myeloma treatment candidate. Health Research: India and Switzerland say they expect to launch joint research projects in health, alongside broader cooperation in life sciences.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

Sep. 7, 2026

Perspectify News

Learn about labels.

Labels

Labels On

Filter

Sep. 29, 2026

Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure

Drug Discovery and Development |

Owner: Mountaingate Capital info about owner

Drug Discovery and Development

Pending

Owned By	Mountaingate Capital through WTWH Media LLC
Year Founded	2010
Website	www.drugdiscoverytrends.com
Domain Registration Year	2019
Access Type	open
Publication Location	United States, Ohio, Cleveland
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Sep. 29, 2026

Pharma stocks: Sun Pharma, Dr Reddy’s, Cipla, Biocon and others in focus today; here's why

Business Today |

Owner: Purie Family info about owner

Business Today

Indeterminate

Owned By	Purie Family through India Today Group
Year Founded	1992
Website	https://www.businesstoday.in/
Domain Registration Year	2005
Access Type	open
Publication Location	India, Noida
Owner Country	India

We welcome your feedback!
If you have comments or corrections, let us know.

Oct. 1, 2026

India's motor car exports witnessing healthy growth in EFTA market: Piyush Goyal

The Economic Times |

Owner: Sahu Jain Family info about owner

Economic Times

Center-right

Owned By	Sahu Jain Family through Bennett, Coleman & Company Ltd
Year Founded	1961
Website	https://economictimes.indiatimes.com/
Domain Registration Year	1996
Access Type	hybrid
Publication Location	India, Noida
Owner Country	India

We welcome your feedback!
If you have comments or corrections, let us know.

15 hours ago

Top biotech deals in September 2026

Labiotech |

Owner: Harvey M. Schwartz info about owner

Labiotech

Neutral

Owned By	Harvey M. Schwartz (CEO) through The Carlyle Group & Inpart
Year Founded	2014
Website	https://www.labiotech.eu/
Domain Registration Year
Access Type	open
Publication Location	Germany, Berlin
Owner Country	Germany

We welcome your feedback!
If you have comments or corrections, let us know.

Sep. 30, 2026

European evangelical body raises concerns over abortion measures in Andorra and Liechtenstein

Christian Daily International |

Owner: Christian Daily International, Inc. info about owner

Christian Daily International

Indeterminate

Owned By	Christian Daily International, Inc. through The Christian Post, Inc (Gordon Showell-Rogers, International Director; Christopher Chou, CEO)
Year Founded	2023
Website	www.christiandaily.com
Domain Registration Year	2003
Access Type	open
Publication Location	United States, New York, Wingdale
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Sep. 30, 2026

CBP Releases Updated Section 232 Guidance for Pharmaceutical Articles and Ingredients

JD Supra - California |

Owner: Aviva Cuyler info about owner

JD Supra

Neutral

Owned By	Aviva Cuyler through JD Supra LLC
Year Founded	2006
Website	https://www.jdsupra.com/
Domain Registration Year	2006
Access Type	open
Publication Location	United States, California, Sausalito
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Sep. 26, 2026

Pharmaceutical Section 232 Tariffs: U.S. Department of Commerce Clarifies Specialty Drug Exemptions Before September 29 Deadline

JD Supra - California |

Owner: Aviva Cuyler info about owner

JD Supra

Neutral

Owned By	Aviva Cuyler through JD Supra LLC
Year Founded	2006
Website	https://www.jdsupra.com/
Domain Registration Year	2006
Access Type	open
Publication Location	United States, California, Sausalito
Owner Country	United States

We welcome your feedback!
If you have comments or corrections, let us know.

Sep. 29, 2026

US waives 100 pc tariff on select Indian speciality drugs: What it means for pharma industry

The Federal |

Owner: P. Satyanarayanan & G. K. Manohar info about owner

The Federal

Neutral

Owned By	P. Satyanarayanan & G. K. Manohar through New Generation Media Corporation Pvt Ltd
Year Founded	2019
Website	https://thefederal.com/
Domain Registration Year	2002
Access Type	hybrid
Publication Location	India, Chennai
Owner Country	India

We welcome your feedback!
If you have comments or corrections, let us know.

As featured in:

@ Journalists!

Join

Helena Bachmann

MUCKRACK.COM

Vlado Apostolov

BALKANINSIGHT.COM

Press releases

Publish your press release

Sep. 25, 2026

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

GlobeNewswire, Inc.

Sep. 18, 2026

Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

GlobeNewswire, Inc.

Jul. 23, 2026

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

GlobeNewswire, Inc.

Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

GlobeNewswire, Inc.

May 19, 2026

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

GlobeNewswire, Inc.

Trump Says 'We Don't Think' Russian Plague Is Bio-Weapon

EU Releases €1.24 Billion for Ukrainian-Made Drones and Munitions

Discover Affinity Group Publishing

Marco Rubio Urges Europe to Defend Western Values and Strengthen Alliance With US

France's Missile Test Draws Fire From Moscow